Aurotioprol

Aurotioprol
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Intramuscular injection
ATC code	M01CB05 (WHO) ;
Identifiers
	IUPAC name Sodium aurothiopropanolsulfonate;
CAS Number	27279-43-2 ;
PubChem CID	44144564;
ChemSpider	8628381;
UNII	G7097J63E9;
CompTox Dashboard (EPA)	DTXSID60912312 ;
ECHA InfoCard	100.043.971
Chemical and physical data
Formula	C3H6AuNaO4S2
Molar mass	390.15 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C(C(CS(=O)(=O)[O-])O)[S-].[Na+].[Au+];
	InChI InChI=1S/C3H8O4S2.Au.Na/c4-3(1-8)2-9(5,6)7;;/h3-4,8H,1-2H2,(H,5,6,7);;/q;2*+1/p-2; Key:KBWWFTIQBJUOQR-UHFFFAOYSA-L;
	(verify)

Aurotioprol is a gold salt used as an antirheumatic agent.^[1]^[2]

References edit

^ Perrier P, Raffoux C, Thomas P, Tamisier JN, Busson M, Gaucher A, Streiff F (September 1985). "HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis". Annals of the Rheumatic Diseases. 44 (9): 621–4. doi:10.1136/ard.44.9.621. PMC 1001721. PMID 3876081.
^ Veys EM, Mielants H, Verbruggen G (1987). "Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study". Clinical and Experimental Rheumatology. 5 (2): 111–6. PMID 3608266.

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.

Clinical data

AHFS/Drugs.com	International Drug Names
Routes of administration	Intramuscular injection
ATC code	M01CB05 (WHO)
Identifiers
IUPAC name Sodium aurothiopropanolsulfonate
CAS Number	27279-43-2^Y
PubChem CID	44144564
ChemSpider	8628381
UNII	G7097J63E9
CompTox Dashboard (EPA)	DTXSID60912312
ECHA InfoCard	100.043.971
Chemical and physical data
Formula	C₃H₆AuNaO₄S₂
Molar mass	390.15 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES C(C(CS(=O)(=O)[O-])O)[S-].[Na+].[Au+]
InChI InChI=1S/C3H8O4S2.Au.Na/c4-3(1-8)2-9(5,6)7;;/h3-4,8H,1-2H2,(H,5,6,7);;/q;2*+1/p-2 Key:KBWWFTIQBJUOQR-UHFFFAOYSA-L
(verify)